In addition to better screening, there are now more effective treatment options for diabetic eye diseases, particularly diabetic retinopathy and macular oedema.
Since last year, the oral drug Fenofibrate has been prescribed to patients who are in the middle stage of any diabetic eye disease to slow it down.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you